Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
journal contribution
posted on 2024-05-17, 12:13 authored by Mohit Mathur, Jonathan Barratt, Yusuke SuzukiCORRESPONDENCE
History
Author affiliation
College of Life Sciences/Cardiovascular SciencesVersion
- NA (Not Applicable or Unknown)
Published in
New England Journal of MedicineVolume
390Issue
13Pagination
1245 - 1246Publisher
Massachusetts Medical Societyissn
0028-4793eissn
1533-4406Copyright date
2024Publisher DOI
Spatial coverage
United StatesLanguage
enPublisher version
Deposited by
Professor Jonathan BarrattDeposit date
2024-04-26Usage metrics
Categories
No categories selectedLicence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC